Table 5.
Top active substances prescribed to study participants (ATC level 5)
| Name | ATC Code | Frequency (n = 3179) | Percentagea | Trend in use |
|---|---|---|---|---|
| Amlodipine | C08CA01 | 78 | 13 | Medium |
| Aspirin | N02BA01 | 54 | 9 | Low |
| Atenolol | C07AB03 | 62 | 10.3 | Medium |
| Captopril | C09AA01 | 53 | 8.8 | Low |
| Ceftriaxone | J01DD04 | 241 | 40.2 | High |
| Dexamethasone | R01AD03 | 61 | 10.2 | Medium |
| Diclofenac sodium | M01AB05 | 111 | 18.5 | Medium |
| Furosemide | C03CA01 | 68 | 11.3 | Medium |
| Lactulose | A06AD11 | 49 | 8.2 | Low |
| Metformin | A10BA02 | 53 | 8.8 | Low |
| Metoclopramide | A03FA01 | 86 | 14.3 | Medium |
| Metronidazole | A01AB17 | 119 | 19.8 | Medium |
| Omeprazole | A02BC01 | 308 | 51.3 | High |
| Paracetamol | N02BE01 | 305 | 50.8 | High |
| Simvastatin | C10AA01 | 63 | 10.5 | Medium |
aPercentages given with respect to the total sample size of patients